Eagle LogoPEPTIDE INITIATIVE

Peptide Database

Goals
Fat LossMuscle BuildingInjury HealingAnti-AgingCognitive EnhancementSleep OptimizationImmune SupportGut HealingSkin RejuvenationSexual Health
Peptides
5-Amino-1MQ
Weight Management
Abarelix
Hormone Support
Acetyl Hexapeptide-3 (Argireline)
Cosmetic
Adipotide
Weight Management
Adrenomedullin
Healing & Recovery
Alexamorelin
Growth Hormone
Angiotensin (1-7)
Healing & Recovery
AOD-9604
Weight Management
Apelin-13
Healing & Recovery
ARA-290 (Cibinetide)
Healing & Recovery
Bestatin (Ubenimex)
Immune
BPC-157
Healing & Recovery
Buserelin
Hormone Support
Cagrilintide
Weight Management
CagriSema
Weight Management
Capromorelin
Growth Hormone
Cartalax
Anti-Aging
Cathelicidin (hCAP-18 / Synthetic Derivatives)
Immune
Cerebrolysin
Cognitive
Cerluten
Cognitive
Cetrorelix
Hormone Support
Chonluten
Immune
CJC-1295 (No DAC)
Growth Hormone
CJC-1295 with DAC
Growth Hormone
Cortexin
Cognitive
Crystagen
Immune
Daptomycin
Immune
Defensin (HBD-2)
Immune
Defensin (HBD-3)
Immune
Degarelix
Hormone Support
Dihexa
Cognitive
DSIP (Delta Sleep-Inducing Peptide)
Sleep & Recovery
Dulaglutide
Weight Management
Enalapril
Healing & Recovery
Epithalon
Anti-Aging
Exenatide
Weight Management
Fertirelin
Hormone Support
FOXO4-DRI
Anti-Aging
Ganirelix
Hormone Support
GHK-Cu (Copper Peptide)
Cosmetic
GHRH (1-29)
Growth Hormone
GHRP-2
Growth Hormone
GHRP-6 (Growth Hormone Releasing Peptide-6)
Growth Hormone
Glutathione
Anti-Aging
Gonadorelin (GnRH)
Hormone Support
Gramicidin
Immune
Hexarelin
Growth Hormone
Human Chorionic Gonadotropin (HCG)
Hormone Support
Human Growth Hormone (HGH)
Growth Hormone
IGF-1 LR3
Growth Hormone
Immunoxel (Dzherelo)
Immune
Imunofan
Immune
Intermedin (Adrenomedullin-2)
Healing & Recovery
Ipamorelin
Growth Hormone
Kisspeptin-10
Sexual Health
KPV (Alpha-MSH Fragment)
Healing & Recovery
Lactoferricin B
Immune
Larazotide
Healing & Recovery
Lentinan
Immune
Leuphasyl
Cosmetic
Leuprolide
Hormone Support
Liraglutide
Weight Management
Livagen
Anti-Aging
Lixisenatide
Weight Management
LL-37
Immune
Macimorelin
Growth Hormone
Magainin-2
Immune
Mazdutide
Weight Management
Melanotan-2
Cosmetic
MK-677 (Ibutamoren)
Growth Hormone
MOTS-c
Metabolic
Myristoyl Pentapeptide-17
Cosmetic
N-Acetyl Selank
Cognitive
N-Acetyl Semax Amidate
Cognitive
NAD+
Mitochondrial
Nafarelin
Hormone Support
Natriuretic Peptide (ANP)
Healing & Recovery
Nesiritide (BNP)
Healing & Recovery
Nisin
Immune
Noopept (Omberacetam)
Cognitive
Orforglipron
Weight Management
Ovagen
Anti-Aging
Oxytocin Acetate
Hormone Support
P21 (P021)
Cognitive
PACAP-38
Healing & Recovery
Palmitoyl Oligopeptide
Cosmetic
Palmitoyl Pentapeptide-4 (Matrixyl)
Cosmetic
Palmitoyl Tetrapeptide-7
Cosmetic
Palmitoyl Tripeptide-1
Cosmetic
Pancragen
Metabolic
PEG-MGF
Healing & Recovery
Pemvidutide
Weight Management
Pentadecapeptide (BPC Analog)
Healing & Recovery
Pidotimod
Immune
Pinealon
Cognitive
PNC-27
Immune
Polymyxin B
Immune
Pralmorelin (GHRP-2)
Growth Hormone
Pramlintide
Weight Management
Prostamax
Hormone Support
PT-141 (Bremelanotide)
Sexual Health
Relaxin-2 (Serelaxin)
Healing & Recovery
Retatrutide
Weight Management
Selank
Cognitive
Semaglutide
Weight Management
Semax
Cognitive
Sermorelin
Growth Hormone
Setmelanotide
Weight Management
SLU-PP-332
Metabolic
SM-130686
Growth Hormone
Snap-8
Cosmetic
SS-31 (Elamipretide)
Mitochondrial
Substance P Antagonists
Healing & Recovery
Survodutide
Weight Management
SYN-AKE
Cosmetic
Tabimorelin
Growth Hormone
TB-500
Healing & Recovery
Tesamorelin
Growth Hormone
Testagen
Hormone Support
Thymalin
Immune
Thymopentin (TP-5)
Immune
Thymopoietin
Immune
Thymosin Alpha-1
Immune
Thymosin Beta-4
Healing & Recovery
Thymulin (FTS)
Immune
Thymulin Analog (PAT)
Healing & Recovery
Tirzepatide
Weight Management
Tripeptide-29
Cosmetic
Triptorelin
Hormone Support
Ularitide
Healing & Recovery
Urocortin
Healing & Recovery
Ventfort
Anti-Aging
Vesilute
Hormone Support
Vilon
Immune
VIP (Vasoactive Intestinal Peptide)
Healing & Recovery
Xenin-25
Metabolic
Ziconotide (Prialt)
Healing & Recovery
Total Peptides: 137
Back to Home

BPC-157

The "Wolverine peptide" known for its remarkable healing properties across tendons, ligaments, muscles, and the gut.

Written by Michael Carroll — Owner, Director of Research · Reviewed by the Peptide Initiative Research Team · Editorial standards

Healing & RecoveryResearch compound

Suggested dose

250 – 500 mcg

Once dailyCycle: 4-6 weeksOnset: Moderate (1-2 weeks)
4-6 hoursHalf-life
~100%Bioavailability(subcutaneous)
1419.53 g/molMolecular weight
Strong preclinicalEvidence level

Compound profile

BPC-157 scientific & efficacy data

Healing & Recovery

Peptide profile

Primary Benefit8.5
Secondary Benefit7.8
Additional Benefit7.2

Strong preclinical

BPC-157

250 mcg · Once daily

Molecular formula

C62H98N16O22

Mol. weight
1419.53 g/mol
CAS number
137525-51-0
PubChem
9941444
Developed · 1992
Predrag Sikirić
University of Zagreb

Amino acid sequence

Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val

Primary Benefit

Accelerates wound healing

Secondary Benefit

Promotes tendon repair

Additional Benefit

Promotes ligament repair

Dosing

How much BPC-157 do I take?

250 – 500 mcg

250 – 500 mcg

Covers all 3 documented dose levels · timing · dose-adjustment guidance.

Every documented dose level

PhaseDoseFrequency
Weeks 1-2250 mcgOnce daily
Weeks 4-6250-500 mcgTwice daily
Weeks 6-8500 mcgTwice daily
BPC-157Once daily

How much peptide is in your bottle?

Look at the label on the vial. It’s the number next to the unit — like "5 mg". Labeled in IU? Switch the unit to IU.

Type a number to continue.
0

Suitability

Is BPC-157 right for me?

Best for injury recovery & post-surgery healing

Best for

Tendon and ligament injuries

Sprains, strains, tears, tendinitis - BPC-157 accelerates collagen synthesis and tissue repair [1][7]

Gut healing

IBS, leaky gut, ulcers, inflammatory bowel conditions [1][11] - derived from gastric juice, it has a natural affinity for digestive tissue [3][5]

Muscle injuries

Strains, post-workout recovery, chronic muscle issues - promotes angiogenesis and growth factor expression [8]

Joint problems

Arthritis support, joint pain, cartilage issues - anti-inflammatory and regenerative properties [9][10]

Post-surgical recovery

Accelerating healing after procedures - works systemically to enhance the body's repair mechanisms [2]

Consider alternatives if

Growth hormone optimizationCJC-1295, Ipamorelin
Cognitive enhancementSemax, Selank
Anti-aging / skinGHK-Cu, Epithalon

Do not use if

PregnancyBreastfeedingActive cancerHistory of cancer

Use with caution if

You have any chronic medical conditionsYou are taking prescription medicationsYou have a history of allergic reactions to peptides

Not sure?

Compare BPC-157 with similar peptides to find the best fit for your goals.

Administration

How do I use BPC-157?

Subcutaneous injection

Route

Subcutaneous injection (into the fatty tissue just under the skin)

Best sites

Lower abdomen (2 inches from navel)Outer thigh (middle third)Back of upper arm

Covers reconstitution · step-by-step technique · storage · a sample daily schedule.

Safety

Is BPC-157 safe?

3 common side effects · 2 serious

BPC-157 is a gastric pentadecapeptide with strong preclinical evidence from extensive animal studies spanning over 25 years of research.

Critical limitation: BPC-157 has NOT completed Phase 3 human clinical trials. [5] No FDA approval exists. [4][6] Safety data comes primarily from rat and mouse studies, with only limited Phase 1-2 human data.

[4][5] Animal studies show no toxicity at therapeutic doses, but human data is insufficient for regulatory approval. [2][4] The peptide is unregulated, and no standardized manufacturing or quality control requirements exist for research compounds.

[6][7] Individual responses may vary significantly, and serious medical supervision is essential before use, particularly if you have gastrointestinal conditions, take medications, or have pre-existing medical conditions.

BPC-157's evidence base is categorized as 'Strong preclinical' based on extensive rat models demonstrating accelerated healing across multiple tissue types including tendon, ligament, muscle, and GI mucosa. [1] However, no completed Phase 3 human clinical trials exist.

[5] Published human data is limited to a small number of early-phase studies and case reports. [4][5] Manufacturing quality varies significantly between suppliers as the compound is not regulated by the FDA [6][7].

Less common

HeadacheFatigueHot/cold sensations

These typically resolve with continued use or dose adjustment.

Common side effects · experienced by some users

  • Injection site redness

    Usually resolves in 30-60 minutes

    Management: Rotate sites, ice if needed

  • Mild nausea

    Typically only first few doses

    Management: Take with food, reduce dose temporarily

  • Dizziness

    Rare, usually with higher doses

    Management: Reduce dose, stay hydrated

Stop and seek help if

  • If you experience severe or persistent injection site reactions or signs of infection
  • If you develop signs of an allergic reaction such as difficulty breathing, swelling, or severe rash
  • If healing progress plateaus after 6+ weeks of continuous use, indicating need for reassessment or alternative approaches

Always consult with a healthcare provider before discontinuing BPC-157, especially if used for active injury recovery. Do not stop abruptly without medical guidance as this may impact healing outcomes.

With other peptides

With medications

  • Caution:Blood Thinners (Warfarin
  • Caution:etc.)
  • Caution:NSAIDs (Ibuprofen

With supplements

  • Safe:Vitamin D3 — Generally safe and may support overall health
  • Safe:Magnesium — Generally safe and may enhance peptide absorption

Effectiveness

How do I know BPC-157 is working?

Strong preclinical · first signs week 1-2

Evidence level

Strong preclinical

(extensive animal studies)

70/100

Regulatory status

Research compound

Onset of effects

Moderate

(1-2 weeks)

How it works

BPC-157 works by interacting with specific receptors and signaling pathways in your body.

[5] When administered, it triggers beneficial responses that lead to its therapeutic effects. Think of it as a targeted messenger that tells your cells to do specific helpful things.

The deeper mechanism

BPC-157 exerts its effects through receptor-mediated signaling cascades. [5] The peptide binds to its target receptor(s), initiating intracellular signaling that ultimately produces the observed physiological effects. Research continues to fully characterize the complete mechanism of action. [4][5]

What to expect

  1. Week 1-2

    What you might notice

    • Reduced inflammation
    • Less pain at injury site
    • Improved gut comfort (if used for digestive issues)

    What's normal

    • Subtle changes—don't expect dramatic results yet
    • Some users feel nothing this early

    What's next

    • Continue protocol
    • Maintain consistent timing
  2. Week 3-4

    What you might notice

    • Noticeable improvement in injury healing
    • Increased mobility
    • Better function in affected area
    • Significant gut symptom relief

    What's normal

    • This is when most users see clear benefits
    • Progress may be gradual, not sudden

    What's next

    • Assess if dose adjustment needed
    • Continue if seeing progress
  3. Week 5-6+

    What you might notice

    • Substantial or complete healing
    • Return to normal activity
    • Lasting improvements

    What's normal

    • Healing timeline varies by injury severity
    • Some chronic conditions need longer

    What's next

    • Consider stopping if healed
    • Take 2-4 week break
    • Can restart if needed

Signs it's working

For injuries

  • Less pain at rest
  • Less pain with movement
  • Improved range of motion
  • Faster recovery between workouts
  • Reduced swelling

For gut issues

  • Less bloating
  • Reduced pain after eating
  • More regular digestion
  • Decreased symptoms overall

Not seeing results? Common reasons

  • Not allowing enough time—most peptides require consistent use for weeks to months before full effects are apparent
  • Inconsistent dosing schedule—maintaining regular administration is critical for optimal results
  • Improper storage or handling leading to degraded product
  • Individual variation in response—genetics, health status, and other factors affect how you respond
  • Dose may need adjustment—consult with your healthcare provider about optimizing your protocol

Key research

2018[1]
“BPC 157 and Standard Angiogenic Growth Factors. Gastrointestinal Tract Healing, Lessons from Tendon, Ligament, Muscle and Bone Healing”Seiwerth S, Rucman R, Turkovic B, et al.Finding: Review from the University of Zagreb group that developed BPC 157: in animal models it was consistently effective across acute and chronic injuries of the oesophagus, stomach, duodenum and lower gastrointestinal tract, given intraperitoneally, by mouth or locally, and with the same regimens it improved tendon, ligament and bone healing, which the authors attribute partly to its angiogenic effect.View study
2021[2]
“Stable Gastric Pentadecapeptide BPC 157 and Wound Healing”Seiwerth S, Milavic M, Vukojevic J, et al.Finding: Accelerated wound closure and tissue regeneration in multiple animal models.View study
2011[3]
“Effect of BPC 157 on tendon healing”Chang et al.Finding: Significantly improved tendon-to-bone healing in rat rotator cuff model.View study
2025[4]
“Multifunctionality and Possible Medical Application of the BPC 157 Peptide—Literature and Patent Review”Józwiak M, Bauer M, Kamysz W, Kleczkowska PFinding: Open-access review (Pharmaceuticals 2025). BPC 157 has not been approved for use in standard medicine by the FDA or other regulators owing to the absence of sufficient and comprehensive clinical studies in humans. Most, if not all, studies are limited to small animal models (rats and mice); human studies are scarce — a retrospective 12-patient knee-pain study and a Phase I trial in 42 healthy volunteers started in 2015, for which submission of results was cancelled in 2016. No toxic dose has been determined in rat and dog toxicity studies. The review calls for in-depth analysis of the mechanism of action, describing it as still unknown.View study
2026[5]
“BPC-157 as an Investigational Peptide Therapeutic: Biopharmaceutical Challenges, Formulation Strategies, and Translational Development Barriers”Mateescu DM, Gavrilescu DM, Constantinescu FE, et al.Finding: Open-access narrative review (Pharmaceutics 2026). BPC-157 has no approved formulation, no validated dosing regimen and no completed Phase II trial; early-phase Pliva investigations in inflammatory bowel disease (PL-10, PLD-116, PL14736) were not followed by Phase II or III trials, and available clinical data come from fewer than 30 subjects across three uncontrolled pilot studies. It was derived from a protein fragment in human gastric juice, and the GI tract is its most extensively characterised domain. It acts through multiple overlapping signalling pathways — documented targets include VEGFR2, Egr-1, the NO system and growth hormone receptor signalling — though no high-affinity receptor binding site has been identified and its molecular target remains formally unknown. Parenteral administration is described as the most pharmacokinetically reliable route; oral effects in rodents may reflect local mucosal action.View study
2025[6]
“Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review”Vasireddi N, Hahamyan H, Salata MJ, et al.Finding: Systematic review (HSS Journal 2025) of 36 studies (35 preclinical, 1 clinical). BPC-157 lacks US FDA approval and is banned in professional sports. In preclinical models it improved functional, structural and biomechanical outcomes in muscle, tendon, ligament and bone injuries; preclinical safety studies showed no adverse effects, and no clinical safety data were found. Adverse effects are possible due to unregulated manufacturing, contamination, or unknown clinical safety.View study
2026[7]
“From Regeneration to Analgesia: The Role of BPC-157 in Tissue Repair and Pain Management”Yuan C, Demers A, Silva-Ortiz V, et al.Finding: Open-access review (Int J Mol Sci 2026). Preclinical evidence shows BPC-157 supports angiogenesis, collagen synthesis and fibroblast activity, enhancing healing of muscle, tendon, ligament, bone and GI tissue. Human research is limited to small pilot studies. BPC-157 does not have FDA approval; complaints from unregulated use may reflect unregulated production and variable dosing, and standardisation and regulation of its preparation is described as necessary to prevent contamination.View study
2009[8]
“Modulatory effect of gastric pentadecapeptide BPC 157 on angiogenesis in muscle and tendon healing”Brcic L, Brcic I, Staresinic M, Novinscak T, Sikiric P, Seiwerth SFinding: In rat crushed-muscle and transected muscle and tendon models, immunohistochemistry (VEGF, CD34, FVIII) showed adequately modulated angiogenesis in BPC 157-treated animals; the authors conclude BPC 157 stimulates angiogenesis by up-regulating VEGF expression, with no direct angiogenic effect on cell cultures.View study
1997[9]
“Pentadecapeptide BPC 157 positively affects both non-steroidal anti-inflammatory agent-induced gastrointestinal lesions and adjuvant arthritis in rats”Sikiric P, Seiwerth S, Grabarevic Z, et al.Finding: In rat adjuvant arthritis (14 days to 1 year), BPC 157 (10 µg or 10 ng/kg i.p.) reduced lesion development and, given as therapy for established arthritis, produced a salutary effect after 2 weeks that persisted at 1 year; the authors conclude the data point to a special anti-inflammatory and mucosal-integrity protective effect.View study
2021[10]
“Intra-Articular Injection of BPC 157 for Multiple Types of Knee Pain”Lee E, Padgett BFinding: Retrospective chart review of 16 patients: 11 of 12 given intra-articular BPC 157 alone reported significant improvement in knee pain (14 of 16 overall including BPC 157 + TB4). No standardised outcome tools were used. The authors describe BPC 157 as a peptide with regenerative properties with the potential to repair tears and build cartilage.View study
2020[11]
“BPC 157 Rescued NSAID-cytotoxicity Via Stabilizing Intestinal Permeability and Enhancing Cytoprotection”Park JM, Lee HJ, Sikiric P, Hahm KBFinding: Review (Curr Pharm Des 2020) describing, for the first time, the potential rescuing actions of BPC 157 against leaky gut syndrome after NSAID administration, via stabilised intestinal permeability and cytoprotection.View study
2026[12]
“Tendon, Ligament, and Muscle Injury, Osteotendinous, Myotendinous, and Muscle-to-Bone Junction Therapy Perspectives with Growth Factors and Stable Gastric Pentadecapeptide BPC 157—A Review”Matek D, Matek I, Japjec M, et al.Finding: Open-access review (Pharmaceuticals 2026). Without any carrier, BPC 157 given systemically or locally combined beneficial effects on tendon, ligament and muscle injuries and junctional healing; in rat studies, across systemic (intraperitoneal, intragastric, drinking water) and local (cream) administration, it consistently demonstrated efficacy.View study

Clinical trials

BPC-157 tested in people

2 registered studies, 1 still enrolling.

2registered studies
1recruiting now
0phase 3 or 4
0with published results

By phase

Phase 11
Phase 21

A trial spanning two phases is counted in both, so these can sum above the total. Observational studies carry no phase.

What kind of research

Gave the drug2
Records only0

About 162 people took part in the studies that actually administered BPC-157. Observational studies analyse the records of people already taking it — nobody was given anything for the study, so they are counted separately and cannot show cause and effect.

Most recent

  • NCT07437547Phase 2Recruiting120 enrolled

    BPC 157 for Acute Hamstring Muscle Strain Repair

    Hudson Biotech

  • NCT02637284Phase 1Unknown42 enrolled

    PCO-02 - Safety and Pharmacokinetics Trial

    PharmaCotherapia d.o.o.

See all 2 trials for BPC-157

Sources: ClinicalTrials.gov, the EU Clinical Trials Information System and ISRCTN, deduplicated so a study registered twice is counted once. A study is counted when BPC-157 is named as an intervention; studies that only mention it in passing are not.

Questions

Frequently asked about BPC-157

How long does BPC-157 take to work?

Most users begin noticing effects within 1-2 weeks, with significant improvements typically occurring around weeks 3-4. For severe or chronic injuries, it may take 6-8 weeks for full benefits.

Can I take BPC-157 orally?

While some research shows oral BPC-157 may be effective for gut issues, subcutaneous injection is generally preferred for systemic and localized healing as it provides more reliable absorption [1][5].

Should I inject near the injury site?

Injecting near the injury site can provide localized benefits, but BPC-157 also works systemically. [12] Many users alternate between local and abdominal injections.

Can I stack BPC-157 with other peptides?

Yes, BPC-157 is commonly stacked with TB-500 for enhanced healing. It can also be used alongside growth hormone secretagogues without issues.

Do I need to cycle BPC-157?

Cycling is recommended. A typical protocol is 4-6 weeks on, followed by 2-4 weeks off before restarting if needed. This helps maintain effectiveness and allows assessment of healing progress.

Ready for the protocol?

Every dosing tier, administration route, timing note, and dose-adjustment rule for BPC-157, on one page.

Medical disclaimer

BPC-157 is an investigational research compound not approved by the FDA for human therapeutic use. This information is for educational purposes only and should not be construed as medical advice. Always consult with a qualified healthcare provider before starting any new supplement or treatment protocol.

Last updated: Oct 9, 2026